{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:49:55Z","timestamp":1787064595098,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the project of the Hunan Provincial Natural Science Foundation Committee","award":["No. 2025JJ50566"],"award-info":[{"award-number":["No. 2025JJ50566"]}]},{"name":"the Graduate Student Innovation Project of Hunan University of Traditional Chinese Medicine","award":["No. 2024CX051"],"award-info":[{"award-number":["No. 2024CX051"]}]},{"name":"the General Program of Hunan Provincial Administration of Traditional Chinese Medicine","award":["No. B2023057"],"award-info":[{"award-number":["No. B2023057"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00415-025-13210-0","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T13:34:55Z","timestamp":1750685695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparative efficacy and safety of different durations of dual antiplatelet therapy in acute minor non-cardioembolic stroke: a systematic review and network meta-analysis"],"prefix":"10.1007","volume":"272","author":[{"given":"Wuchaonan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"13210_CR1","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1161\/STROKEAHA.113.002881","volume":"44","author":"M Reeves","year":"2013","unstructured":"Reeves M, Khoury J, Alwell K, Moomaw C, Flaherty M, Woo D, Khatri P, Adeoye O, Ferioli S, Kissela B, Kleindorfer D (2013) Distribution of national institutes of health stroke scale in the Cincinnati\/Northern Kentucky Stroke Study. Stroke 44:3211\u20133213. https:\/\/doi.org\/10.1161\/STROKEAHA.113.002881","journal-title":"Stroke"},{"key":"13210_CR2","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1056\/NEJMoa1412981","volume":"374","author":"P Amarenco","year":"2016","unstructured":"Amarenco P, Lavallee PC, Labreuche J, Albers GW, Bornstein NM, Canhao P, Caplan LR, Donnan GA, Ferro JM, Hennerici MG, Molina C, Rothwell PM, Sissani L, Skoloudik D, Steg PG, Touboul PJ, Uchiyama S, Vicaut E, Wong LK, Investigators TIo (2016) One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med 374:1533\u20131542. https:\/\/doi.org\/10.1056\/NEJMoa1412981","journal-title":"N Engl J Med"},{"key":"13210_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k5130","volume":"363","author":"K Prasad","year":"2018","unstructured":"Prasad K, Siemieniuk R, Hao Q, Guyatt G, O\u2019Donnell M, Lytvyn L, Heen AF, Agoritsas T, Vandvik PO, Gorthi SP, Fisch L, Jusufovic M, Muller J, Booth B, Horton E, Fraiz A, Siemieniuk J, Fobuzi AC, Katragunta N, Rochwerg B (2018) Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline. BMJ 363:k5130. https:\/\/doi.org\/10.1136\/bmj.k5130","journal-title":"BMJ"},{"key":"13210_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/cjn.2022.344","volume":"51","author":"M Heran","year":"2024","unstructured":"Heran M, Lindsay P, Gubitz G, Yu A, Ganesh A, Lund R, Arsenault S, Bickford D, Derbyshire D, Doucette S, Ghrooda E, Harris D, Kanya-Forstner N, Kaplovitch E, Liederman Z, Martiniuk S, McClelland M, Milot G, Minuk J, Otto E, Perry J, Schlamp R, Tampieri D, van Adel B, Volders D, Whelan R, Yip S, Foley N, Smith EE, Dowlatshahi D, Mountain A, Hill MD, Martin C, Shamy M (2024) Canadian stroke best practice recommendations: acute stroke management, 7(th) edition practice guidelines update, 2022. Can J Neurol Sci 51:1\u201331. https:\/\/doi.org\/10.1017\/cjn.2022.344","journal-title":"Can J Neurol Sci"},{"issue":"12","key":"13210_CR5","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 50(12):e344\u2013e418","journal-title":"Stroke"},{"key":"13210_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/23969873211000877","author":"J Dawson","year":"2021","unstructured":"Dawson J, Merwick A, Webb A, Dennis M, Ferrari J, Fonseca AC, European Stroke O (2021) European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA. Eur Stroke J. https:\/\/doi.org\/10.1177\/23969873211000877","journal-title":"Eur Stroke J"},{"key":"13210_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, Wang C, Li H, Meng X, Cui L, Jia J, Dong Q, Xu A, Zeng J, Li Y, Wang Z, Xia H, Johnston SC (2013) Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 369:11\u201319. https:\/\/doi.org\/10.1056\/NEJMoa1215340","journal-title":"N Engl J Med"},{"key":"13210_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"S Claiborne Johnston","year":"2018","unstructured":"Claiborne Johnston S, Donald Easton J, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY (2018) Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med 379:215\u2013225. https:\/\/doi.org\/10.1056\/NEJMoa1800410","journal-title":"N Engl J Med"},{"key":"13210_CR9","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1056\/NEJMc2027491","volume":"383","author":"A Kaushik","year":"2020","unstructured":"Kaushik A, Deora S, Choudhary R (2020) Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA. N Engl J Med 383:1692\u20131693. https:\/\/doi.org\/10.1056\/NEJMc2027491","journal-title":"N Engl J Med"},{"key":"13210_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/jamaneurol.2022.1457","volume":"79","author":"Y Pan","year":"2022","unstructured":"Pan Y, Meng X, Jin A, Johnston SC, Li H, Bath PM, Xie X, Jing J, Lin J, Wang Y, Zhao X, Li Z, Jiang Y, Liu L, Yang H, Cheng J, Wang Z, Wang Y (2022) Time course for benefit and risk with ticagrelor and aspirin in individuals with acute ischemic stroke or transient ischemic attack who carry CYP2C19 loss-of-function alleles: a secondary analysis of the CHANCE-2 randomized clinical trial. JAMA Neurol 79:739\u2013745. https:\/\/doi.org\/10.1001\/jamaneurol.2022.1457","journal-title":"JAMA Neurol"},{"key":"13210_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, Mulrow C, Catala-Lopez F, Gotzsche PC, Dickersin K, Boutron I, Altman DG, Moher D (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162:777\u2013784. https:\/\/doi.org\/10.7326\/M14-2385","journal-title":"Ann Intern Med"},{"key":"13210_CR12","doi-asserted-by":"crossref","unstructured":"Higgins JP, Savovi\u0107 J, Page MJ, et al. (2019) Assessing risk of bias in a randomized trial. 205\u201328","DOI":"10.1002\/9781119536604.ch8"},{"issue":"4\u201312","key":"13210_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.10.028","volume":"139","author":"J Watt","year":"2019","unstructured":"Watt J, Tricco AC, Straus S, Veroniki AA, Naglie G, Drucker AM (2019) Research techniques made simple: network meta-analysis. J Invest Dermatol 139(4\u201312):e11. https:\/\/doi.org\/10.1016\/j.jid.2018.10.028","journal-title":"J Invest Dermatol"},{"key":"13210_CR14","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"13210_CR15","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/s1474-4422(07)70250-8","volume":"6","author":"J Kennedy","year":"2007","unstructured":"Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM (2007) Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 6:961\u2013969. https:\/\/doi.org\/10.1016\/s1474-4422(07)70250-8","journal-title":"Lancet Neurol"},{"key":"13210_CR16","doi-asserted-by":"publisher","first-page":"l2211","DOI":"10.1136\/bmj.l2211","volume":"365","author":"Y Wang","year":"2019","unstructured":"Wang Y, Chen W, Lin Y, Meng X, Chen G, Wang Z, Wu J, Wang D, Li J, Cao Y, Xu Y, Zhang G, Li X, Pan Y, Li H, Zhao X, Liu L, Lin J, Dong K, Jing J, Johnston SC, Wang D, Wang Y, Group PPS (2019) Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial. BMJ 365:l2211. https:\/\/doi.org\/10.1136\/bmj.l2211","journal-title":"BMJ"},{"key":"13210_CR17","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1056\/NEJMoa2111749","volume":"385","author":"Y Wang","year":"2021","unstructured":"Wang Y, Meng X, Wang A, Xie X, Pan Y, Johnston SC, Li H, Bath PM, Dong Q, Xu A, Jing J, Lin J, Niu S, Wang Y, Zhao X, Li Z, Jiang Y, Li W, Liu L, Xu J, Chang L, Wang L, Zhuang X, Zhao J, Feng Y, Man H, Li G, Wang B, Investigators C (2021) Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA. N Engl J Med 385:2520\u20132530. https:\/\/doi.org\/10.1056\/NEJMoa2111749","journal-title":"N Engl J Med"},{"key":"13210_CR18","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1056\/NEJMoa2309137","volume":"389","author":"Y Gao","year":"2023","unstructured":"Gao Y, Chen W, Pan Y, Jing J, Wang C, Johnston SC, Amarenco P, Bath PM, Jiang L, Yang Y, Wang T, Han S, Meng X, Lin J, Zhao X, Liu L, Zhao J, Li Y, Zang Y, Zhang S, Yang H, Yang J, Wang Y, Li D, Wang Y, Liu D, Kang G, Wang Y, Wang Y, Investigators I (2023) Dual antiplatelet treatment up to 72 hours after ischemic stroke. N Engl J Med 389:2413\u20132424. https:\/\/doi.org\/10.1056\/NEJMoa2309137","journal-title":"N Engl J Med"},{"key":"13210_CR19","unstructured":"Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman AJUO (2013) Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. 2013:15"},{"issue":"2","key":"13210_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/clpt.2011.132","volume":"90","author":"SA Scott","year":"2011","unstructured":"Scott SA, Sangkuhl K, Gardner EE et al (2011) Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450\u20132C19 (CYP2C19) genotype and clopidogrel therap. Clin Pharmacol Ther 90(2):328\u2013332. https:\/\/doi.org\/10.1038\/clpt.2011.132","journal-title":"Clin Pharmacol Ther"},{"key":"13210_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000369778","volume":"39","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Wang C, Zheng M, Li Y, Li J, Zhang L, Shang X, Yan C (2015) Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis. Cerebrovasc Dis (Basel, Switzerland) 39:13\u201322. https:\/\/doi.org\/10.1159\/000369778","journal-title":"Cerebrovasc Dis (Basel, Switzerland)"},{"key":"13210_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/ehjqcco\/qcz024","volume":"5","author":"F Pugliese","year":"2019","unstructured":"Pugliese F, Arasaratnam P, Moellenberg M, Dani S (2019) Short- vs. long-term dual antiplatelet therapy in secondary prevention for ischaemic stroke: a network metanalysis. Eur Heart J Qual Care Clin Outcomes 5:298\u2013309. https:\/\/doi.org\/10.1093\/ehjqcco\/qcz024","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"13210_CR23","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1161\/CIRCULATIONAHA.113.003187","volume":"128","author":"KS Wong","year":"2013","unstructured":"Wong KS, Wang Y, Leng X, Mao C, Tang J, Bath PM, Markus HS, Gorelick PB, Liu L, Lin W, Wang Y (2013) Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis. Circulation 128:1656\u20131666. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.003187","journal-title":"Circulation"},{"key":"13210_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k5108","volume":"363","author":"Q Hao","year":"2018","unstructured":"Hao Q, Tampi M, O\u2019Donnell M, Foroutan F, Siemieniuk RA, Guyatt G (2018) Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis. BMJ 363:k5108. https:\/\/doi.org\/10.1136\/bmj.k5108","journal-title":"BMJ"},{"key":"13210_CR25","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1161\/CIRCULATIONAHA.121.053782","volume":"143","author":"G Trifan","year":"2021","unstructured":"Trifan G, Gorelick PB, Testai FD (2021) Efficacy and safety of using dual versus monotherapy antiplatelet agents in secondary stroke prevention: systematic review and meta-analysis of randomized controlled clinical trials. Circulation 143:2441\u20132453. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.053782","journal-title":"Circulation"},{"key":"13210_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1177\/1358863X241265335","volume":"29","author":"M Ahmed","year":"2024","unstructured":"Ahmed M, Ahsan A, Fatima L, Basit J, Nashwan AJ, Ali S, Hamza M, Karalis I, Ahmed R, Alareed A, Ijioma NN, Alraies MC (2024) Efficacy and safety of aspirin plus clopidogrel versus aspirin alone in ischemic stroke or high-risk transient ischemic attack: a meta-analysis of randomized controlled trials. Vasc Med (London, England) 29:517\u2013525. https:\/\/doi.org\/10.1177\/1358863X241265335","journal-title":"Vasc Med (London, England)"},{"key":"13210_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147575","author":"F Nappi","year":"2024","unstructured":"Nappi F (2024) P2Y12 receptor inhibitor for antiaggregant therapies: from molecular pathway to clinical application. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25147575","journal-title":"Int J Mol Sci"},{"key":"13210_CR28","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2217\/pgs-2018-0072","volume":"19","author":"MD Klein","year":"2018","unstructured":"Klein MD, Lee CR, Stouffer GA (2018) Clinical outcomes of CYP2C19 genotype-guided antiplatelet therapy: existing evidence and future directions. Pharmacogenomics 19:1039\u20131046. https:\/\/doi.org\/10.2217\/pgs-2018-0072","journal-title":"Pharmacogenomics"},{"key":"13210_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1212\/WNL.0000000000201661","volume":"100","author":"T Brown","year":"2023","unstructured":"Brown T, Gonzales N (2023) Optimizing choice of dual antiplatelet therapy in CYP2C19 loss-of-function carriers. Neurology 100:223\u2013224. https:\/\/doi.org\/10.1212\/WNL.0000000000201661","journal-title":"Neurology"},{"key":"13210_CR30","doi-asserted-by":"publisher","first-page":"991646","DOI":"10.3389\/fcvm.2022.991646","volume":"9","author":"AB Nguyen","year":"2022","unstructured":"Nguyen AB, Cavallari LH, Rossi JS, Stouffer GA, Lee CR (2022) Evaluation of race and ethnicity disparities in outcome studies of CYP2C19 genotype-guided antiplatelet therapy. Front Cardiovasc Med 9:991646. https:\/\/doi.org\/10.3389\/fcvm.2022.991646","journal-title":"Front Cardiovasc Med"},{"key":"13210_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2217\/pgs-2019-0050","volume":"21","author":"Y Fu","year":"2020","unstructured":"Fu Y, Zhang XY, Qin SB, Nie XY, Shi LW, Shao H, Liu J (2020) Cost-effectiveness of CYP2C19 LOF-guided antiplatelet therapy in Chinese patients with acute coronary syndrome. Pharmacogenomics 21:33\u201342. https:\/\/doi.org\/10.2217\/pgs-2019-0050","journal-title":"Pharmacogenomics"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13210-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13210-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13210-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:13:30Z","timestamp":1757196810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13210-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["13210"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13210-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"474"}}